Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase

Background: Evidence on whether the influenza vaccine could exacerbate immune-related adverse events, including myopericarditis (MP), in patients treated with immune checkpoint inhibitors (ICIs), is still conflicting. We explored this issue through a global real-world approach. Methods: We queried t...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Milo Gatti, Emanuel Raschi, Ugo Moretti, Andrea Ardizzoni, Elisabetta Poluzzi, Igor Diemberger
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	MDPI AG 2021-01-01
سلاسل:	Vaccines
الموضوعات:	influenza vaccine immune checkpoint inhibitors myocarditis pericarditis pharmacovigilance drug–vaccine interaction
الوصول للمادة أونلاين:	https://www.mdpi.com/2076-393X/9/1/19
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!